1 |
YOKOSE C, MCCORMICK N, CHOI H K. The role of diet in hyperuricemia and gout[J]. Curr Opin Rheumatol, 2021, 33(2): 135-144.
|
2 |
DALBETH N, MERRIMAN T R, STAMP L K. Gout[J]. Lancet, 2016, 388(10055): 2039-2052.
|
3 |
ROBINSON P C. Gout-An update of aetiology, genetics, co-morbidities and management[J]. Maturitas, 2018, 118: 67-73.
|
4 |
REY A, BATTEUX B, LAVILLE S M, et al. Acute kidney injury associated with febuxostat and allopurinol: a post-marketing study[J]. Arthritis Res Ther, 2019, 21(1): 229.
|
5 |
郭钦惠, 方 宏, 陈俊文, 等. 非布司他药物相关不良反应文献分析[J]. 中国医学创新, 2020, 17(22): 104-107.
|
6 |
袁 华, 李静华, 封宇飞. 114例别嘌醇不良反应文献分析[J]. 中国药物应用与监测, 2016, 13(6): 359-362.
|
7 |
傅恒涛, 张 苗, 慈小燕, 等. 治疗痛风和高尿酸血症药物的研究进展[J]. 药物评价研究, 2021, 44(8): 1811-1816.
|
8 |
中国科学院中国植物志编辑委员会. 中国植物志·第三十九卷[M]. 北京: 科学出版社, 1988: 250-268.
|
9 |
阮汉利, 张勇慧, 皮慧芳, 等. 蛇菰的化学成分研究[J]. 天然产物研究与开发, 2006, 18(1): 74-75.
|
10 |
阮汉利, 李 娟, 赵晓亚, 等. 筒鞘蛇菰镇痛有效部位的筛选[J]. 医药导报, 2006, 25(5): 383-384.
|
11 |
SUN X, ZHANG L, CAO Y, et al. Anti-neuraminidase activity of chemical constituents of Balanophora involucrata[J]. Biomed Chromatogr, 2020, 34(12): e4949.
|
12 |
周卫华, 石慧娟, 杨梅松竹, 等. 蛇菰水提物对大鼠酒精性肝损伤的保护作用[J]. 中国老年学杂志, 2012, 32(20): 4438-4440.
|
13 |
汤子春, 邹 坤, 汪鋆植, 等. 开口箭与筒鞘蛇菰提取物醒酒作用机制的研究[J]. 时珍国医国药, 2007, 18(12): 2958-2960.
|
14 |
黄徐英, 宋红萍, 柳 鑫, 等. 筒鞘蛇菰乙酸乙酯萃取物的止血作用[J]. 医药导报, 2019, 38(9): 1160-1162.
|
15 |
王 慧, 张红歧, 邬昊洋, 等. 筒鞘蛇菰提取物及松柏苷的抗氧化作用研究[J]. 三峡大学学报(自然科学版), 2009, 31(3): 99-101.
|
16 |
何 玲, 高 辉, 李春艳. 筒鞘蛇菰多糖抗疲劳作用研究[J]. 怀化学院学报, 2011, 30(S1): 43-45.
|
17 |
侯文彬, 周丽丽, 周卫华. 蛇菰水提物对自然衰老小鼠的抗衰老作用研究[J]. 中国民族民间医药, 2012, 21(3): 33.
|
18 |
HO S T, TUNG Y T, HUANG C C, et al. The hypouricemic effect of Balanophora laxiflora extracts and derived phytochemicals in hyperuricemic mice[J]. Evid Based Complement Alternat Med, 2012, 2012: 910152.
|
19 |
WANG Y M, KONG W, WANG L, et al. Multiple-purpose connectivity map analysis reveals the benefits of esculetin to hyperuricemia and renal fibrosis[J]. Int J Mol Sci, 2020, 21(20): 7695.
|
20 |
YANAI H, ADACHI H, HAKOSHIMA M, et al. Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease[J]. Int J Mol Sci, 2021, 22(17): 9221.
|
21 |
LI Y, SHEN Z Y, ZHU B W, et al. Demographic, regional and temporal trends of hyperuricemia epidemics in mainland China from 2000 to 2019: a systematic review and meta-analysis[J]. Glob Health Action, 2021, 14(1): 1874652.
|
22 |
HOU C L, LIU D, WANG M, et al. Novel xanthine oxidase-based cell model using HK-2 cell for screening antihyperuricemic functional compounds[J]. Free Radic Biol Med, 2019, 136: 135-145.
|
23 |
黄佳豪, 李先平, 赵军英, 等. 益生菌缓解高尿酸血症作用机制研究进展 [J/OL]. 食品科学. .
|
24 |
吴 芃, 王 亮, 李海涛, 等. 高尿酸血症模型的建立及降尿酸药物的研究进展[J]. 中国病理生理杂志, 2021, 37(7): 1283-1294.
|
25 |
HUBER T B, HARTLEBEN B, KIM J, et al. Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling[J]. Mol Cell Biol, 2003, 23(14): 4917-4928.
|
26 |
CHEN K Q, LI Y Q, ZHANG X H, et al. The role of the PI3K/AKT signalling pathway in the corneal epithelium: recent updates[J]. Cell Death Dis, 2022, 13(5): 513.
|
27 |
CHEN H J, ZHANG Y, ZOU M M, et al. Bisphenol A aggravates renal apoptosis and necroptosis in selenium-deficient chickens via oxidative stress and PI3K/AKT pathway[J]. J Cell Physiol, 2022, 237(8): 3292-3304.
|
28 |
YUAN Q, TANG B, ZHANG C. Signaling pathways of chronic kidney diseases, implications for therapeutics[J].Signal Transduct Target Ther,2022,7(1): 182.
|
29 |
EL-MAADAWY W H, HASSAN M, HAFIZ E,et al. Co-treatment with Esculin and erythropoietin protects against renal ischemia-reperfusion injury via P2X7 receptor inhibition and PI3K/Akt activation[J]. Sci Rep, 2022, 12(1): 6239.
|
30 |
HU T T, CHEN F, CHEN D, et al. DNMT3a negatively regulates PTEN to activate the PI3K/AKT pathway to aggravate renal fibrosis[J]. Cell Signal, 2022, 96: 110352.
|
31 |
XIAO Q. Cinnamaldehyde attenuates kidney senescence and injury through PI3K/Akt pathway-mediated autophagy via downregulating miR-155[J]. Ren Fail, 2022, 44(1): 601-614.
|
32 |
宋璐霞. 温肾益髓生血方对肾性贫血大鼠肾脏的保护作用及对肾组织PI3K/AKT信号通路影响的实验研究[D]. 北京: 北京中医药大学, 2019.
|
33 |
LI Y Y, TIAN Z H, SU S S, et al. Anti-apoptotic effect of HeidihuangWan in renal tubular epithelial cells via PI3K/Akt/mTOR signaling pathway[J]. J Ethnopharmacol, 2023, 302(Pt A): 115882.
|
34 |
翟志恒, 田 杨, 周玉妮, 等. lncRNA NEAT1激活PI3K/Akt信号通路对Aβ25-35诱导的PC12细胞凋亡的影响及机制[J].解放军医学杂志, 2021,46(12): 1188-1195.
|
35 |
陈彦名. 加味活血四妙汤干预慢性尿酸性肾病进展的临床及动物实验研究[D]. 北京: 北京中医药大学, 2017.
|
36 |
WOZNIAK J, FLOEGE J, OSTENDORF T, et al. Key metalloproteinase-mediated pathways in the kidney[J]. Nat Rev Nephrol, 2021, 17(8): 513-527.
|